Skip to main content
search
Conference

2026 ACCP Annual Meeting

Conference: 2026 ACCP Annual Meeting

Date: September 27 - 29, 2026

Location: Bethesda N Marriott Hotel & Conf Ctr N Bethesda, MD

Certara at the 2026 ACCP Annual Meeting

We are thrilled to participate as an exhibitor at the 2026 American College of Clinical Pharmacology (ACCP) Annual Meeting, held September 27-29, at the Bethesda N Marriott Hotel & Conference Center in North Bethesda, MD.

This year’s theme, “Harnessing changing clinical pharmacology paradigms to improve patient outcomes,” strongly aligns with Certara’s mission to accelerate and improve patient access to innovative therapies through model-informed drug development and regulatory science.

Visit us at our booth to engage with our scientific experts, discover our latest advancements in clinical pharmacology and pharmacometrics, and see how Certara is shaping the future of smarter, faster drug development. We’re proud to showcase our scientific leadership with a substantial presence, including expert-led presentations, scientific posters, and on-site engagement opportunities.

Explore Certara Resources

We are committed to transforming drug development through innovative science and customer-centric solutions. Learn more about our capabilities:

  • Clinical Pharmacology: Achieve faster, data-driven clinical development decisions with our integrated strategies, from first-in-human to late-phase trials.
  • Pharmacometrics: Uncover actionable insights with industry-leading pharmacometric modeling and exposure-response analyses.
  • Modeling & Simulation Services: Reduce risks and speed up development with robust simulation technologies supporting evidence-based decisions throughout the lifecycle.
  • Simcyp™ PBPK Platform: Confidently predict clinical outcomes using the Simcyp™ PBPK platform for ADME evaluation, drug-drug interactions, and special population responses.
  • Quantitative Systems Pharmacology (QSP): Deepen disease and drug action understanding to enhance target validation and trial design through QSP modeling.
  • Regulatory Science & Strategy: Navigate global regulatory pathways with precision via Certara’s expert-led strategies, submission support, and agency engagement services.

Join us in redefining the future of clinical pharmacology. Together, we can optimize therapeutic outcomes and create a positive impact on patient lives.

Request a meeting with our experts


You May Also Like

Allometric Approach in pharmacokinetics when and how to use it
Allometric Approach in pharmacokinetics when and how to use itWebinar

Allometric Approach in pharmacokinetics when and how to use it

ADC Dose Optimization: Applying Model-Informed Strategies in Development
ADC Dose Optimization: Applying Model-Informed Strategies in DevelopmentBlog

ADC Dose Optimization: Applying Model-Informed Strategies in Development

Extending the Value of Antibody–Drug Conjugates: Model-Informed Labeling, Expansion, and Market Access
Extending the Value of Antibody–Drug Conjugates: Model-Informed Labeling, Expansion, and Market AccessOn-Demand Webinar

Extending the Value of Antibody–Drug Conjugates: Model-Informed Labeling, Expansion, and Market Access